Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Endoscopic retrograde cholangiopancreatography Stories

2013-05-17 08:24:19

NATICK, Mass., May 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) is scheduled to participate in Digestive Disease Week (DDW®) 2013, May 18-21 in Orlando, Fla. More than 24 clinical presentations will feature new data and analyses on products including the Boston Scientific SpyGlass® Direct Visualization System, WallFlex® Biliary RX Stent System and Expect® 19 Flex Endoscopic Ultrasound Aspiration Needle. "The insights and data included in these...

2013-01-08 16:23:35

FLUSHING, N.Y., Jan. 8, 2013 /PRNewswire-USNewswire/ -- Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Kaumudi Somnay. (Photo: http://photos.prnewswire.com/prnh/20130108/DC39051) In fact, of the nation's 870,000 active physicians and dentists, just five percent consistently received top scores from their patients on sites like Vitals (http://www.vitals.com), qualifying them for this honor in 2012. Millions of patients go online each...

2012-11-15 16:26:29

ASGE encourages patients and families to learn about the disease and seek support OAK BROOK, Ill., Nov. 15, 2012 /PRNewswire-USNewswire/ -- This November, the American Society for Gastrointestinal Endoscopy (ASGE) is raising awareness about pancreatic cancer and encouraging patients and their families to become educated about the disease, to ask their doctor about treatments and to reach out for support. Pancreatic cancer is the fourth leading cause of cancer deaths in the United States....

2012-10-03 10:23:56

BURTONSVILLE, Md., Oct. 3, 2012 /PRNewswire/ -- ChiRhoClin, Inc. is pleased to notify the medical community that ChiRhoStim® (Human Secretin for Injection) has returned to the market. In cooperation with the FDA CDER Drug Shortage Team, ChiRhoClin is permitted to market the current batch of ChiRhoStim® until its new manufacturing site is operational by the beginning of 2013. ChiRhoStim® is an orphan drug product that aids in the diagnoses of pancreatic cancer and pancreatic...

2012-07-17 02:27:36

MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- Xlumena, Inc. announces that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage. The device was previously approved for the treatment of pancreatic pseudocysts. The enhanced indication gives endoscopists a new minimally-invasive tool to create a secure connection between the gallbladder or bile duct and the gastrointestinal tract. Clinical research is showing that treatment with the...

2012-05-18 02:24:43

NATICK, Mass., May 18, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week(®) (DDW), May 19 - 22 in San Diego. The analyses involve the SpyGlass(®) Direct Visualization System, WallFlex® Biliary RX Stent, Expect(TM) 19 Flex Endoscopic Ultrasound Aspiration Needle and Resolution® Clip. "The volume and quality of presentations that include Boston...

2012-04-12 09:52:52

Dozens of therapies have been tried, but study led by University of Michigan physicians is first to show effective prevention of post-ERCP pancreatitis A study in the current issue of the New England Journal of Medicine shows a serious complication of ERCP, a procedure commonly used to diagnose and treat problems of the bile and pancreatic ducts, may be eliminated with a single dose medication. The finding is significant in helping patients avoid a condition known as post-ERCP...

2012-03-22 02:25:24

NATICK, Mass., March 22, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces the U.S. and international launch of the WallFlex(®) Biliary Transhepatic Stent System. This third-generation stent platform is now available with a percutaneous delivery system designed for use by interventional radiologists in the palliative treatment of biliary strictures produced by malignant tumors. The WallFlex Biliary Transhepatic Fully Covered Stent System is also available for the...

2011-11-09 06:00:00

PARIS, November 9, 2011 /PRNewswire/ -- Now available for endoscopic dilation of the Sphincter of Oddi following sphincterotomy Boston Scientific Corporation's (NYSE: BSX) CRE(TM) Wireguided Balloon Dilator is now CE marked for endoscopic dilation of the Sphincter of Oddi following sphincterotomy. The new indication, which supplements the product's current indication for use in the alimentary (digestive) tract, lets physicians perform Dilation Assisted Stone Extraction...

2011-10-18 07:30:00

NATICK, Mass., Oct. 18, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures (narrowing or blockages). This multi-center, prospective study enrolled 187 patients at 13 centers in 11 countries worldwide. Lead Investigators in the study are Professor Jacques Deviere, M.D., Ph.D., of Hospital Erasme in Brussels,...